![Hal Landy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hal Landy
Technik-/Wissenschafts-/F&E-Leiter bei
Valerion Therapeutics LLC
Profil
Hal Landy is currently the Director at Phoenicis Therapeutics, Inc. and the Chief Medical Officer at Valerion Therapeutics LLC.
Previously, he worked as the Medical Director at EMD Serono, Inc., Vice President-Clinical Development at Repligen Corp., Vice President-Clinical Research at Genzyme Corp., and Chief Medical Officer & VP-Medical Affairs at Enobia Pharma, Inc. He holds a doctorate degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Hal Landy
| Unternehmen | Position | Beginn |
|---|---|---|
Valerion Therapeutics LLC
 Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Develops targeted therapies for orphan genetic diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Phoenicis Therapeutics, Inc.
 Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing therapeutic | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hal Landy
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Technik-/Wissenschafts-/F&E-Leiter | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
| REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Hal Landy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Valerion Therapeutics LLC
Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Develops targeted therapies for orphan genetic diseases | Health Technology |
Phoenicis Therapeutics, Inc.
Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing therapeutic | Health Technology |
